Table 1.
Illustrative Example of COVID-19 Vaccine Equity Index Calculations Using Simulated Data
| Method 1—adjusted | R1 | R2 | R3 | CVEI |
|---|---|---|---|---|
| Non-Hispanic White | 0.95 | 0.78 | 0.89 | 0.66 |
| Black/African American | 1.17 | 1.19 | 1.44 | 2.00 |
| Asian | 1.02 | 0.84 | 1.24 | 1.06 |
| Hispanic | 1.10 | 2.21 | 1.17 | 2.84 |
| Method 2—unadjusted | R1 | R2 | R3 | CVEI |
|---|---|---|---|---|
| Non-Hispanic White |
0.95 |
0.73 |
0.91 |
0.63 |
| Black/African American |
1.17 |
1.13 |
1.42 |
1.87 |
| Asian |
1.02 |
0.96 |
1.30 |
1.27 |
| Hispanic | 1.10 | 2.42 | 1.13 | 3.01 |
Comparison of adjusted and unadjusted methods for calculating the CVEI. Highlighted cells reflect values far in excess of equity (value much >1), and signify potential areas for intervention using targeted vaccination efforts.
Bold represents CVEI, COVID-19 vaccine equity index.